Synthetic biological approaches to natural product biosynthesis
- PMID: 22221832
- PMCID: PMC3418455
- DOI: 10.1016/j.copbio.2011.12.016
Synthetic biological approaches to natural product biosynthesis
Abstract
Small molecules produced in Nature possess exquisite chemical diversity and continue to be an inspiration for the development of new therapeutic agents. In their host organisms, natural products are assembled and modified using dedicated biosynthetic pathways. By rationally reprogramming and manipulating these pathways, unnatural metabolites containing enhanced structural features that were otherwise inaccessible can be obtained. Additionally, new chemical entities can be synthesized by developing the enzymes that carry out these complicated chemical reactions into biocatalysts. In this review, we will discuss a variety of combinatorial biosynthetic strategies, their technical challenges, and highlight some recent (since 2007) examples of rationally designed metabolites, as well as platforms that have been established for the production and modification of clinically important pharmaceutical compounds.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Figures
References
-
- Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009;325:161–165. - PubMed
-
- Carter GT. Natural products and Pharma 2011: strategic changes spur new opportunities. Nat Prod Rep. 2011;28:1783–1789. - PubMed
-
- Kennedy J. Mutasynthesis, chemobiosynthesis, and back to semi-synthesis: combining synthetic chemistry and biosynthetic engineering for diversifying natural products. Nat Prod Rep. 2008;25:25–34. - PubMed
-
- Brakhage AA, Schroeckh V. Fungal secondary metabolites - strategies to activate silent gene clusters. Fungal Genet Biol. 2011;48:15–22. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
